The development of new medications is a multi-phase process. It starts with preclinical testing, followed by clinical trials in three phases. Phase I tests the drug's safety in a small group of healthy volunteers. Phase II assesses the drug's efficacy and side effects in a larger patient group, and Phase III involves large-scale testing to confirm its effectiveness and monitor adverse reactions.
